The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism
Titel:
The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism
Auteur:
Soto, Lilian Sabugo, Francisca Catalan, Diego Wurmann, Pamela Cermenatti, Tomás Gatica, Héctor Aravena, Octavio Salazar, Lorena Aguillón, Juan Carlos Cuchacovich, Miguel